Catalyst

Slingshot members are tracking this event:

Progenics (PGNX) Phase 2 Results Evaluating SPECT/CT Agent 1404 Published in Journal of Nuclear Medicine

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
PGNX

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 24, 2017
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 2, Spect/ct, 1404, Journal Of Nuclear Medicine